| Followers | 17 |
| Posts | 5009 |
| Boards Moderated | 0 |
| Alias Born | 04/13/2016 |
Monday, August 17, 2020 10:52:38 PM
Me: "Financing."
Rayo: "That would be selling shares on the NASDAQ then."
No. KBLB cannot uplist until after the shares are sold. Maxim will have to sell the proposed shares while KBLB is still on the OTC.
The investors that MAXIM intends to sell to are not long-term holders. These are folks who want to make sure they can turn a quick buck. I'm guessing KBLB will have to price the shares around 6 cents in order to attract $24 million in interest.
Anyone purchasing shares at .149 would likely lose money in the near term. Perhaps in a year or so after this financing (and reverse split, if that happens) the share price will recover.
Without production and sales, KBLB is playing a weak hand. (That was the point of TRUTH's original post.) Weak hands don't attract angel investors. They attract vultures.
Would I break out champagne if Maxim sold $24 million in shares at .149? No. That's not a bad price, so I wouldn't be crying over spilt milk, but not much cause for celebration. What price would make me happy? Let's say I'd get a smile on my face at 50 cents.
But the problem, of course, is that no one is going to pay 50 cents for a secondary offering when you can buy shares on the OTC at 10 to 15 cents. I don't think they would even pay .149 at the moment. We were down to 11.5 cents recently and it won't take much to push KBLB down to those levels again. The offering will be considerably below 11.5 cents/share, if it ever goes out. That will bring the out the vultures needed to make the secondary offering successful.
Rayo: "That would be selling shares on the NASDAQ then."
No. KBLB cannot uplist until after the shares are sold. Maxim will have to sell the proposed shares while KBLB is still on the OTC.
What level of financing would be a win to you? .14 presplit?
The investors that MAXIM intends to sell to are not long-term holders. These are folks who want to make sure they can turn a quick buck. I'm guessing KBLB will have to price the shares around 6 cents in order to attract $24 million in interest.
Anyone purchasing shares at .149 would likely lose money in the near term. Perhaps in a year or so after this financing (and reverse split, if that happens) the share price will recover.
What terms are cause for calling them vultures today?
Without production and sales, KBLB is playing a weak hand. (That was the point of TRUTH's original post.) Weak hands don't attract angel investors. They attract vultures.
Would I break out champagne if Maxim sold $24 million in shares at .149? No. That's not a bad price, so I wouldn't be crying over spilt milk, but not much cause for celebration. What price would make me happy? Let's say I'd get a smile on my face at 50 cents.
But the problem, of course, is that no one is going to pay 50 cents for a secondary offering when you can buy shares on the OTC at 10 to 15 cents. I don't think they would even pay .149 at the moment. We were down to 11.5 cents recently and it won't take much to push KBLB down to those levels again. The offering will be considerably below 11.5 cents/share, if it ever goes out. That will bring the out the vultures needed to make the secondary offering successful.
Recent KBLB News
- Why Advanced Materials Are Reshaping the Industrial Ecosystem • GlobeNewswire Inc. • 04/07/2026 01:15:00 PM
- The intersection of biotechnology, advanced materials, and molecular biology • IH Market News • 04/07/2026 06:56:44 AM
- Spider Silk Has Been a Lab Curiosity for Decades; One Company Just Produced Over a Ton of It in a Single Month • AllPennyStocks.com • 04/06/2026 05:06:15 PM
- Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High • GlobeNewswire Inc. • 04/06/2026 11:05:00 AM
- From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk • GlobeNewswire Inc. • 04/02/2026 01:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:38:14 PM
- Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan • GlobeNewswire Inc. • 03/30/2026 11:05:00 AM
- Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics • GlobeNewswire Inc. • 03/23/2026 11:05:00 AM
- Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial Scale • GlobeNewswire Inc. • 03/18/2026 12:51:04 PM
- 24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making • GlobeNewswire Inc. • 03/11/2026 01:15:00 PM
- Washington’s Textile Strategy: How DPA Title III Could Strengthen U.S. Manufacturing and Defense Supply Chains • GlobeNewswire Inc. • 03/05/2026 03:05:00 PM
- Kraig Biocraft Laboratories Targets New Industrial and Defense Biomaterials as "Project Atlas" Hits Major Milestone • GlobeNewswire Inc. • 03/05/2026 12:05:00 PM
- Defense Supply Chains and Strategic Materials Drive the Morning Bid • GlobeNewswire Inc. • 03/03/2026 02:51:45 PM
- Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength • GlobeNewswire Inc. • 02/27/2026 02:45:46 PM
- Biotech and Big Tech Drive the Morning Narrative • GlobeNewswire Inc. • 02/24/2026 03:17:14 PM
- 24/7 Market News- “Somewhere in Michigan”: National Geographic Spotlights Kraig Biocraft Laboratories Science Powering Recombinant Spider Silk Production • GlobeNewswire Inc. • 02/24/2026 01:05:00 PM
- Biotech Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger • GlobeNewswire Inc. • 02/23/2026 02:36:14 PM
- Kraig Biocraft Laboratories’ Spider Silk Advancements Featured as the Cover of National Geographic's March 2026 Issue • GlobeNewswire Inc. • 02/23/2026 12:05:00 PM
- $30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum • GlobeNewswire Inc. • 02/19/2026 04:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 04:17:09 PM
- 24/7 Market News- It’s Not Synthetic, It’s Real. Kraig Labs Nears Spider Silk Breakthrough • GlobeNewswire Inc. • 02/18/2026 01:45:00 PM
- AI, Advanced Materials and Enterprise Security Drive Small-Cap Momentum • GlobeNewswire Inc. • 02/17/2026 03:11:28 PM
- Kraig Biocraft Laboratories Activates First Wave of 2026 Production Program • GlobeNewswire Inc. • 02/17/2026 12:05:00 PM
- 24/7 Market News - Not Magic, Just Science: Kraig Labs’ Transgenic Silkworms Make History at Scale • GlobeNewswire Inc. • 02/11/2026 01:35:00 PM
- AI, Genomics, and CRISPR Signal a New Phase of Biological Innovation • GlobeNewswire Inc. • 02/10/2026 02:29:10 PM
